Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
about
Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, GreeceThe presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis CAutoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the diseaseImmunoglobulin GM and KM Allotypes and Prevalence of Anti-LKM1 Autoantibodies in Patients with Hepatitis C Virus InfectionPrevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohortAutoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristicsAutoantibodies in chronic hepatitis C: A clinical perspectivePotential viral pathogenic mechanism in human type 1 diabetesLiver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver diseaseThe cytoskeleton of digestive epithelia in health and disease.Autoantibodies and liver disease: uses and abuses.Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alphaIs autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis?Review article: autoimmune hepatitis -- current management and challenges.Autoimmune hepatitis and its variant syndromes.Genetic distinctions between autoimmune hepatitis in Italy and North America.Recurrent acute hepatitis associated with use of cetirizine.Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot studyClinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.Autoimmune hepatitis: a review of current diagnosis and treatment.Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.Clinical significance of the detection of antinuclear antibodies in patients with acute hepatitis a.The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.Management of chronic hepatitis C.Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitisThe revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan.Management of patients with difficult autoimmune hepatitis.Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.Study of non-organ-specific antibodies in children with genotype 4 chronic hepatitis C.Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.Polyreactive antibodies in adaptive immune responses to viruses.Autoimmune manifestations in viral hepatitis.Host factors determining the efficacy of hepatitis C treatment.Clinical aspects of indirect immunofluorescence for autoimmune diseases.Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.
P2860
Q24799970-EB61C7B5-8882-4E6E-8C71-07293ACD352AQ24801439-C2C8186B-CAFF-4FB1-A240-F304E5B8F3B2Q24804699-BB76DBBD-84F7-4DC6-92EF-013E83320178Q27473220-0848A708-C6F0-4BDD-BC01-EFC6507D0E23Q27477841-B85E49D3-4601-45E2-98ED-606F353DD359Q28087726-9F7B5EC7-A3A5-4F61-A81E-B8F8CE0BD704Q28088556-A84F1DD9-2B60-43F2-9378-5C840E074F0DQ28656023-8BA29AC9-F5DD-47EA-A3F6-DAC2C2B168C9Q30846833-A2D48423-EC07-439E-B698-C7FFFEEF7517Q33795637-A7E3191B-4306-43CD-A02F-3BA465E3FD6BQ33796503-9C4DE671-D947-4A5A-9E4B-DBC83A4C0184Q33829963-D5DB2013-AF50-42FE-837F-EF011266D9D6Q33909777-5B808282-9DFF-44E5-81DB-F6435CF4907AQ34041429-F67947FE-4BF2-44D6-9FB2-A48D0EC383CAQ34369116-5CA83713-994E-4F07-9320-7803C876EFFCQ34371115-33295BE6-194C-4C4B-80CB-ADB11A1BC061Q34406835-96809A99-20D1-4212-88A6-16F43E24B7EFQ34551111-05DD3811-AFAD-49F7-A983-5EB023A8FC52Q34605699-3E9B4E1C-747F-4ABC-9E50-1F3C9E9EB3DAQ34626547-B88BE755-98D2-4D05-898B-7BBD71CB36DEQ35094267-E5CCF678-2AF5-4CC5-AD8E-1C21D3B2463FQ35126088-1AC8F239-834F-4D0D-A5BA-2BC95D5D3F4BQ35195460-F1CF5A2C-BDB1-4F2C-83EC-296CF859D0DAQ35350742-35FE19F5-DAF1-46A8-9817-90539215B295Q35522138-754A9735-FFAB-459B-BE87-CE550BE7AD4DQ35769853-835AD97C-9391-4D92-85F7-E7EA55F4F7FDQ35914823-BAC12309-AD4F-4696-9468-274CBE7322E5Q36231193-F3B8332C-C613-4B65-AD99-5EAAF01E9EB8Q36285235-7E56EE9F-73A8-468C-89D6-0B1B799B539FQ36379083-C5B30BBA-1661-403A-92B2-9D1C739A0535Q36490242-250F3FED-CD7F-4158-85EB-6AC02A1D6C20Q36641415-FF07C320-9982-4332-8065-5D6411F9FED0Q37645723-8E79B888-B683-4E7A-9A6F-477CCAB3C84AQ37672213-B73BFA9D-8075-40B8-9EC5-0E9F2EDC03C5Q37883979-774610AF-0B80-486F-87E1-D3A8CF26B7EDQ37951868-7C20E18D-2FEE-451D-B0C4-019DBDA9F719Q38046450-0E94BBA8-5939-47AF-8612-2CF76803E7CFQ38056077-B618AF31-5329-4DB8-848C-45AA00BF53A5Q38382986-A99A64AE-F3A8-4399-8811-143506B27F69Q38497449-0E05A0E3-8F36-4603-8EE4-041FC3DC78FB
P2860
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Serum autoantibodies in chroni ...... impact on the disease profile.
@ast
Serum autoantibodies in chroni ...... impact on the disease profile.
@en
Serum autoantibodies in chroni ...... impact on the disease profile.
@nl
type
label
Serum autoantibodies in chroni ...... impact on the disease profile.
@ast
Serum autoantibodies in chroni ...... impact on the disease profile.
@en
Serum autoantibodies in chroni ...... impact on the disease profile.
@nl
prefLabel
Serum autoantibodies in chroni ...... impact on the disease profile.
@ast
Serum autoantibodies in chroni ...... impact on the disease profile.
@en
Serum autoantibodies in chroni ...... impact on the disease profile.
@nl
P2093
P356
P1433
P1476
Serum autoantibodies in chroni ...... impact on the disease profile.
@en
P2093
Bianchi FB
Cataleta M
Francesconi R
Muratori L
Muratori P
Valentini P
P304
P356
10.1002/HEP.510260305
P407
P577
1997-09-01T00:00:00Z